Drug Eluting Balloon in peripherAl inTErvention For Below The Knee Angioplasty Evaluation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 142 participants.

Also called NCT01558505

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 142 participants (enrolled count) (from the registry)
Sponsor
Leonardo Bolognese, MD (from the registry)
Registry
  • NCT NCT01558505
Other papers using this trial's data
  • Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia Circulation, 2013-08-06 DOI, PubMed 23797811

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
Not reported
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01558505. Randomized; double masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2012-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Drug Eluting Balloon in peripherAl inTErvention For Below The Knee Angioplasty Evaluation
Acronym
DEBATE-BTK
Condition
Critical Limb Ischemia
Intervention (Device)
PEB
Intervention (Device)
POBA
Lead sponsor
Leonardo Bolognese, MD (class: other)

Record details

Record id
cardio:ct-nct01558505
Content hash
462858a1546b47d88ce1907209ca15ae8e38188395780e741ab89b551d8a7bb3